Dyne Therapeutics' DYNE-101 shows promising Phase 1/2 results for myotonic dystrophy type 1, with plans for Accelerated ...

BBC News presenter Clive Myrie sparked a flurry of concerned messages on social media on Monday night after he appeared on ...

EXCLUSIVE: Dr Alasdair Scott explained the common causes behind BBC News and Mastermind presenter Clive Myrie's droopy eye ...

EXCLUSIVE: A doctor explained the common causes behind BBC News and Mastermind host Clive Myrie's droopy eye condition, which ...

BBC News at Six host Clive Myrie sparked fears over his health as he presented the news with a 'droopy eye', after he said he was suffering from an infection, but a doctor has now explained what could ...

BBC News viewers were worried about presenter Clive Myrie after he appeared on Monday's Six O'Clock News with a droopy eye - ...

Oct. 24, 2024 — A new mouse model mimicking the liver symptoms of myotonic dystrophy type 1 -- the most prevalent form of adult-onset muscular dystrophy -- provides insight into why patients ...

(RTTNews) - Dyne Therapeutics, Inc. (DYN) Friday announced encouraging data from its ongoing Phase 1/2 ACHIEVE trial of DYNE-101 in patients with myotonic dystrophy type 1 (DM1). Myotonic dystrophy ...

Dyne Therapeutics (NASDAQ:DYN) reported clinical data from its ongoing Phase 1/2 trial of DYNE-101 in patients with myotonic dystrophy type 1. Shares down about 22% in early trade. DYNE-101 continued ...

Researchers at the Experimental and Clinical Research Center (ECRC), a joint institution of the Max Delbrück Center and ...

THE WEEK’S MOST POPULAR SONGS RANKED BY ADULT ALTERNATIVE RADIO AIRPLAY DETECTIONS, AS MEASURED BY MEDIABASE AND PROVIDED BY LUMINATE. STATIONS ARE ELECTRONICALLY MONITORED 24 HOURS A DAY ...

The first to unmask all of its opponents’ spies wins. “This is my favorite party game when mixing kids and adults,” says Scott Cooper, owner of Seattle-based Blue Highway Games. A cross ...